View by Specialty

Trending

PC0924Price_Graphic_01_WEB
September 17, 2024
2 min read
Save

Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents

Neurology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
April 05, 2024
1 min read
Save

Collaboration to advance small activating RNA therapeutics for central nervous system

Collaboration to advance small activating RNA therapeutics for central nervous system

A London-based biotech firm has announced a collaboration and licensing agreement with a Japanese pharmaceutical firm for discovery, development and commercialization of small activating RNA therapeutics for rare neurodegenerative diseases.

SPONSORED CONTENT
April 04, 2024
1 min read
Save

Amylyx pulls ALS drug Relyvrio from market in US, Canada

Amylyx pulls ALS drug Relyvrio from market in US, Canada

Amylyx Pharmaceuticals Inc. announced Relyvrio, its amyotrophic lateral sclerosis therapeutic, will be removed from the market in the United States and Canada, effective immediately.

Trending

PC0924Price_Graphic_01_WEB
September 17, 2024
2 min read
Save

Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents

SPONSORED CONTENT
April 04, 2024
1 min read
Save

Neurosurgical ablation system receives limited commercial launch

Neurosurgical ablation system receives limited commercial launch

A Minnesota-based medical technology company announced a limited commercial launch of its OneRF Ablation System, which creates radiofrequency lesions in nervous tissue for functional neurosurgical procedures.

SPONSORED CONTENT
April 03, 2024
1 min read
Save

Seizure frequency reduced as much as 85% in phase 1/2a studies of Dravet syndrome drug

Seizure frequency reduced as much as 85% in phase 1/2a studies of Dravet syndrome drug

Seizure frequency was reduced as much as 85% at 3 months in young patients with Dravet syndrome treated with a proprietary antisense oligonucleotide, according to results of phase 1/2a studies released by the manufacturer.

SPONSORED CONTENT
April 03, 2024
2 min read
Save

Education level correlated with functional decline in Black adults with high tau levels

Education level correlated with functional decline in Black adults  with high tau levels

Higher education levels may protect against cognitive and functional difficulties for Black individuals with high levels of tau, indicating Alzheimer’s pathology, according to research from the Journal of Alzheimer’s Disease.

SPONSORED CONTENT
April 02, 2024
3 min read
Save

Prolonged use of some hormone therapies may increase risk for brain tumors

Prolonged use of some hormone therapies may increase risk for brain tumors

The prolonged use of certain progestogen hormone drugs — such as medrogestone, medroxyprogesterone acetate and promegestone — increased the risk for developing intracranial meningioma, according to data published in The BMJ.

SPONSORED CONTENT
April 02, 2024
1 min read
Save

Intra-molecular compound advanced as potential disease-modifying therapy for ALS

Intra-molecular compound advanced as potential disease-modifying therapy for ALS

A Cincinnati-based life sciences company announced that one of its development candidates, ASHA-624, will be advanced as a potential disease modifying therapy for amyotrophic lateral sclerosis.

SPONSORED CONTENT
April 02, 2024
1 min read
Save

Eisai submits supplemental biologics license application to FDA for monthly IV Leqembi

Eisai submits supplemental biologics license application to FDA for monthly IV Leqembi

Eisai and Biogen have submitted a supplemental biologics license application to the FDA for monthly IV maintenance dosing of Leqembi to treat Alzheimer’s disease in patients with mild cognitive impairment or mild dementia.

SPONSORED CONTENT
April 01, 2024
3 min read
Save

Point-of-care brain wave monitoring can help improve concussion care

Point-of-care brain wave monitoring can help improve concussion care

Despite the brain being one of the most important organs of the body, breakthroughs in brain health, specifically the way we measure cognition, have been largely unchanged in decades.

SPONSORED CONTENT
April 01, 2024
2 min read
Save

Regular exercise associated with recommended duration of sleep, reduced insomnia symptoms

Regular exercise associated with recommended duration of sleep, reduced insomnia symptoms

Exercise just two to three times a week reduced the risk for multiple insomnia symptoms and extreme sleep durations both short and long, a study published in BMJ Open showed.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails